PIQ.AX ASX
Proteomics International Laboratories Ltd.
1W: +4.3%
1M: -22.6%
3M: -22.6%
YTD: -73.6%
1Y: -60.0%
3Y: -86.7%
5Y: -88.9%
A$0.12 ($0.09)
+0.01 (+4.17%)
Weekly Expected Move ±12.2%
A$0
A$0
A$0
A$0
A$0
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$278K
-71.1% ▼
5Y CAGR: -26.7%
Gross Profit
-$9M
-1044.3% ▼
Operating Income
-$12M
-11.9% ▼
Net Income
-$9M
-5.5% ▼
EPS (Diluted)
$-0.05
+4.1% ▲
EBITDA
-$11M
-10.8% ▼
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| Revenue | $1M | $730K | $892K | $960K | $278K |
| YoY Growth | +13.6% | -51.0% | +22.2% | +7.6% | -71.1% |
| Cost of Revenue | $2M | $2M | $2M | $0 | $9M |
| Gross Profit | -$569K | -$2M | -$1M | $960K | -$9M |
| Gross Margin | -38.2% | -221.1% | -125.9% | 100.0% | -3262.0% |
| R&D Expenses | $2M | $2M | $0 | $0 | $0 |
| SG&A Expenses | $4M | $5M | $2M | $6M | $3M |
| Operating Expenses | $8M | $10M | $8M | $12M | $3M |
| Operating Income | -$5M | -$6M | -$9M | -$11M | -$12M |
| Operating Margin | -334.2% | -871.6% | -1022.8% | -1105.7% | -4275.7% |
| Interest Expense | $3K | $0 | $23K | $0 | $41K |
| Income Before Tax | -$5M | -$6M | -$9M | -$8M | -$11M |
| Tax Expense | $2M | -$148K | -$2M | $0 | -$2M |
| Net Income | -$5M | -$6M | -$6M | -$8M | -$9M |
| Net Margin | -333.9% | -853.6% | -714.7% | -844.9% | -3078.9% |
| EPS (Diluted) | $-0.05 | $-0.05 | $-0.05 | $-0.05 | $-0.05 |
| EBITDA | -$5M | -$8M | -$8M | -$10M | -$11M |
| Shares Outstanding | 106M | 116M | 126M | 150M | 164M |